Hong Kong IPO Fundraising in 2025: What HKEX’s #1 Ranking Means for Regulated Fintech in 2026
This briefing explains why Hong Kong topped global IPO fundraising tables in 2025, and what that signal means for regulated fintech, brokers, and payment businesses planning capital moves in 2026. We focus on what HKEX itself published, and we separate “IPO equity funds raised” from broader fundraising claims.
If you are weighing an IPO, a dual-track process, or licensing by acquisition, the takeaway is not a marketing narrative. It is how liquidity, investor attention, and diligence standards tend to shift when one venue regains global leadership.
Publish Date
27 Jan 2026
Reading Time
12 minutes
Category
Legal News
Jurisdiction
Hong Kong
What HKEX’s 2025 IPO fundraising ranking actually says
HKEX published a 2025 global ranking based on IPO equity funds raised, using Dealogic data. In that table, Hong Kong ranked #1 with US$37.416bn raised.
The same table shows other large venues behind it, including Nasdaq, India’s major exchanges, and NYSE. The rankings are useful because they compare venues on a like-for-like metric, rather than mixing IPOs with secondary placements.
If you have seen different totals in the press, it is usually a definition issue. Some figures rely on earlier cut-offs, different inclusion rules, or different classifications of listing types.
Liquidity matters as much as IPO day: what HKEX reported on trading activity
IPO leadership tends to follow liquidity. In its 2025 “Year in Review,” HKEX highlighted a sharp improvement in cash-market activity. It reported average daily turnover of HK$255.8bn for the first 11 months of 2025, up 95% year-on-year.
HKEX also reported 106 new listings raising HK$274.6bn, based on a snapshot dated 19 December 2025 in the same release. That is a time-bounded number, but it supports the broader liquidity point: the market was active enough to sustain both primary issuance and trading.
For operators, this links directly to execution quality. Better turnover usually means tighter spreads, more stable aftermarket support, and a more realistic follow-on fundraising plan.
Hong Kong vs NYSE and India in 2025: why the league table is not the whole story
A league table does not tell you whether your company can list, or whether pricing will be attractive. It tells you where capital concentrated under one measurement.
For regulated fintech, the practical value is how it shapes investor expectations. When a venue leads in IPO fundraising, bankers push more mandates there. More mandates can attract more sector-specialist investors. That typically raises the “proof bar” for governance and controls, not lowers it.
The “tech bid” and the DeepSeek narrative: what is confirmed and what is framing
HKEX itself linked part of the 2025 momentum to a “DeepSeek moment” and broader market reforms. That is an issuer-side explanation, not a causal proof.
What is measurable is the market backdrop. Hang Seng Indexes reported that the Hang Seng TECH Index finished 2025 up 23.5%. A stronger tech tape is one condition that supports IPO appetite and risk-taking.
If you compare against the US tech benchmark, Nasdaq’s own year review reported the Nasdaq Composite finished 2025 up 21.2%. The point is not that one market “won.” The point is that Hong Kong had a credible risk-on backdrop for tech-led listings.
What this means for regulated fintech in 2026
Fundraising and exits: venue optionality may improve, but diligence tightens
A stronger IPO market is not a shortcut. Public investors price uncertainty aggressively, especially in regulated businesses.
If you are an EMI/PI, broker, or a group with crypto exposure, the early questions are predictable. Investors will ask what you are authorised to do, what you actually do, and how you prove controls operate. They will also want a clean story around outsourcing, complaints, and incident handling.
M&A knock-on effect: IPO windows can spill into private pricing
When IPO windows look healthier, private valuations can react. It can lift expectations for “platform” assets and regulated targets, including companies sold for market entry.
If you plan licensing by acquisition, you should assume more competition for clean targets and more scrutiny on compliance portability after closing. The licence is rarely the only asset. The asset is the licence plus a control environment that survives a change of ownership.
Cross-border licensing narratives must be explainable in plain English
Public markets punish complexity that cannot be explained. If your group spans multiple regulators, you need a simple map of permitted activities, revenue by licence, and where key risks sit.
If you cannot summarise your regulatory footprint in a few minutes, investor trust will degrade before diligence even starts.
What breaks in practice for fintech listings and dual-track processes
The most common failure is not “market timing.” It is an evidence gap.
Teams underestimate the public-market standard for control proof. They present policies without operational records, or they treat outsourcing oversight as a vendor list. Banks and partners also re-underwrite the business when ownership or profile changes, which can expose weaknesses in safeguarding, AML escalation, or incident handling.
A second failure is scope ambiguity. If the product flow does not match licence permissions, investors assume hidden risk. Fixing that late is expensive.
Decision checklist for founders and investors
- Define the objective: IPO, dual-track, or M&A exit in 2026.
- Build a controls evidence pack: governance, AML, safeguarding, outsourcing, incidents.
- Clarify licence scope vs flows: permitted activities mapped to revenue and customer journeys.
- Model liquidity and follow-ons: plan beyond “IPO day” fundraising.
- Stress-test timing and approvals: be realistic about sequencing and disclosure readiness.
How Legasset supports fundraising readiness in regulated fintech
We help founders and investors translate regulated operations into investor-grade clarity. That includes licence scope mapping, group structuring, and a controls evidence pack that stands up to diligence.
We also support dual-track planning where M&A and IPO readiness overlap. The goal is fewer surprises when scrutiny rises.
Schedule a consultation right now.
Hong Kong IPO Fundraising: Questions Regulated Fintech Teams Ask
Why do Hong Kong IPO fundraising figures differ across sources?
Most differences come from definitions, cut-offs, and what is included as an IPO. Exchange-published tables often use a specific “IPO equity funds raised” methodology.
Does HKEX being #1 mean Hong Kong is the best venue for every fintech?
No. The ranking is a market-wide signal. Your fit depends on business model, disclosure readiness, shareholder structure, and regulatory footprint.
What is the fastest way to improve IPO readiness for a regulated business?
Build an evidence pack that proves controls operate. Investors and banks test governance, AML effectiveness, safeguarding discipline, and outsourcing oversight early.
How does a stronger IPO market affect licensing-by-acquisition deals?
It can lift valuation expectations and increase competition for clean regulated targets. It also raises the diligence bar on compliance portability after closing.
Which metric should we watch beyond “IPO funds raised”?
Liquidity and follow-on capacity. Primary issuance is only one part of a sustainable capital plan.
